Moyamoya Disease Diagnosis
Moyamoya Disease Diagnosis
Three different questions are being answered, and they are answered by three different studies. The first is whether the vessels are narrowed and whether the collateral network has formed — that is MRI and MR angiography. The second is how far the process has gone and what supply is available to work with — that is catheter angiography. The third, and the one most often missing from a workup done elsewhere, is whether the circulation can still increase flow when the brain demands it — that is a perfusion study, usually with a challenge agent. The diagnosis can be made without the third. The decision usually cannot.
MRI and MR angiography: the study that finds it
For most patients this pair of studies is enough to establish the diagnosis. MR angiography shows narrowing or absence of flow in the terminal internal carotid arteries and in the origins of the arteries that arise from them. The MRI itself shows the collateral network as a speckled pattern of flow voids at the base of the brain, and it shows the consequences: an infarct, evidence of an older one the patient never had symptoms from, and the state of the tissue that is being supplied.
Two findings on MRI are worth asking about specifically, because they change the conversation. The first is evidence of previous bleeding — the residue left behind by blood, which indicates an old event in a patient who never knew about one, and which moves the patient towards the haemorrhagic form. The second is the extent of injury already sustained, because it is the best available guide to what recovery can be expected and it is the reason the timing of surgery matters.
Where the diagnosis is uncertain on MRI, or where surgery is being planned, angiography is the next step rather than a replacement.
Catheter angiography: the reference study
Angiography remains the study that defines the extent of the disease and the stage it has reached, and it remains the study on which the operation is planned. The reason is not resolution alone. It is that angiography shows the vessels filling in time: arterial phase, then the collateral network, then venous drainage. A static image cannot distinguish the fine collateral vessels from the main circulation, and that distinction is the diagnosis.
It also demonstrates the supply that surgery would use. A bypass connects an artery from outside the skull — usually the superficial temporal artery, a branch of the external carotid — to a vessel on the surface of the brain. Whether that artery is of adequate calibre, where it runs, and which cortical branch is a suitable recipient are questions answered by the angiogram. It is therefore performed by the team that would carry out the operation, because the images are the plan rather than a report about one.
The third thing angiography settles is the one that changes management most directly when it is positive: whether an aneurysm is present. Aneurysms on the collateral and perforating vessels occur more often than chance in this condition, and when a patient has bled, finding one identifies the source and adds a second target to the plan.
Perfusion: how much reserve is left
Anatomy says what the vessels look like. Reserve says what they can still do, and the two are frequently discordant. The measurement is made by imaging blood flow before and after a challenge: acetazolamide is given, which dilates the small vessels, and the flow is measured again. Where the reserve is intact, flow rises after the challenge. Where it is exhausted, it does not — and in some territories it falls, because the challenge dilates vessels in better-supplied regions and diverts flow away from the ones that were already marginal.
What an exhausted reserve means in practice is that the brain is already running at its maximum capacity. It has no headroom for a fever, for dehydration, for a drop in blood pressure, or for the increased demand of a crying fit. That is the state in which transient attacks occur, and it is the state in which revascularisation is discussed rather than deferred. It is also the measurement that makes sense of the patient whose anatomy looks modest but whose symptoms are frequent.
This study is the one most often absent from a workup performed elsewhere, and its absence is usually why an opinion given abroad is equivocal. A patient can be told the vessels are narrowed and, on that basis alone, cannot be told much else — because the narrowing does not say whether the brain is coping. Where a perfusion study has not been done and surgery is being considered, arranging one is usually the highest-value next step.
The stage, and what it does and does not tell you
The angiographic staging system describes how far the process has advanced, from narrowing of the terminal carotid alone, through the appearance and then the growth of the collateral network, to the complete disappearance of the main channels, and finally to a stage in which the collateral supply itself recedes. It is a description of a sequence, and it is what allows two reports to be compared.
It is not a severity score in the way patients usually read one, and this is worth saying because a high stage number is frightening without explanation. A later stage often means that a collateral circulation has formed and is doing the work — which is better than a narrowed vessel with nothing behind it. What the stage does not tell you is whether the brain is being adequately supplied, and that is the perfusion study's job. Reading the two together is the whole of the assessment.
What else produces this picture
The same angiographic appearance can arise in the setting of another condition, and when it does, the term moyamoya syndrome is used rather than moyamoya disease. The list is specific and worth going through: sickle cell disease, neurofibromatosis type 1, Down syndrome, previous radiotherapy to the head, thyroid disease, and several autoimmune conditions among them. Distinguishing the two changes the prognosis, changes what else needs treating, and changes what a family is told about screening relatives.
The other distinction that matters in practice is unilateral disease. Where only one side is involved, the criteria for moyamoya disease are not met and the picture is called probable moyamoya disease. This is not a benign label: a proportion of these patients go on to develop changes on the other side, which is why they are followed with imaging rather than discharged. A family told that "it is only on one side, so it is not moyamoya" should be told the second half of that sentence as well.
What a workup here adds up to
A complete assessment answers six questions, and the value of a second opinion is usually concentrated in whichever of them the original workup did not answer. Whether both sides are involved. How far the narrowing has gone, on angiography. How well the collateral network is developed. Whether an aneurysm is present. Whether this patient's disease is ischaemic or haemorrhagic. And how much reserve is left — the one that is missing most often, and the one that most often decides.
The opinion we return is written rather than verbal, and it states what the images show, whether the studies are sufficient, what should be added, and what would be followed rather than operated on.